Once-Weekly Insulin Shows Promise in Type 2 Diabetes Treatment
Chicago: Researchers at a recent American Diabetes Association meeting reported that efsitora, experimental once-weekly insulin, was comparable to daily insulins in nearly a thousand adults with type 2 diabetes in three late-stage trials. The trials, …